Andrew J. Fishleder

1.7k total citations
50 papers, 1.3k citations indexed

About

Andrew J. Fishleder is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Andrew J. Fishleder has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 14 papers in Pathology and Forensic Medicine and 12 papers in Hematology. Recurrent topics in Andrew J. Fishleder's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Innovations in Medical Education (5 papers). Andrew J. Fishleder is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Innovations in Medical Education (5 papers). Andrew J. Fishleder collaborates with scholars based in United States and Netherlands. Andrew J. Fishleder's co-authors include Raymond R. Tubbs, Raymond Tubbs, James K. Weick, Mariana G. Hewson, Hannah Copeland, Michael D. Linden, Glenn H. Segal, William E. Katzin, Alan L. Hull and Bruce A. Sebek and has published in prestigious journals such as New England Journal of Medicine, JAMA and Blood.

In The Last Decade

Andrew J. Fishleder

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew J. Fishleder United States 19 426 328 315 266 235 50 1.3k
Henry A. Azar United States 20 323 0.8× 239 0.7× 180 0.6× 251 0.9× 138 0.6× 52 1.2k
F Deméocq France 22 234 0.5× 312 1.0× 231 0.7× 564 2.1× 129 0.5× 78 1.5k
Leonardo Potenza Italy 22 307 0.7× 483 1.5× 354 1.1× 444 1.7× 252 1.1× 88 1.4k
John M. Flexner United States 25 1.1k 2.6× 643 2.0× 480 1.5× 285 1.1× 443 1.9× 45 1.9k
Maria Gilleece United Kingdom 20 197 0.5× 278 0.8× 405 1.3× 535 2.0× 394 1.7× 54 1.4k
J. E. Curtis Canada 18 103 0.2× 231 0.7× 259 0.8× 465 1.7× 180 0.8× 38 1.1k
Tim H. Parmley United States 26 168 0.4× 245 0.7× 210 0.7× 118 0.4× 197 0.8× 74 1.8k
S Milan United Kingdom 21 263 0.6× 559 1.7× 131 0.4× 847 3.2× 141 0.6× 41 1.5k
WE Fibbe Netherlands 24 319 0.7× 498 1.5× 302 1.0× 823 3.1× 759 3.2× 36 1.9k
Dennis P. O’Malley United States 25 654 1.5× 552 1.7× 467 1.5× 318 1.2× 242 1.0× 92 1.9k

Countries citing papers authored by Andrew J. Fishleder

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Fishleder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Fishleder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Fishleder more than expected).

Fields of papers citing papers by Andrew J. Fishleder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Fishleder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Fishleder. The network helps show where Andrew J. Fishleder may publish in the future.

Co-authorship network of co-authors of Andrew J. Fishleder

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Fishleder. A scholar is included among the top collaborators of Andrew J. Fishleder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Fishleder. Andrew J. Fishleder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maitra, Anirban, et al.. (2000). Cytoplasmic Inclusions in Leukocytes. American Journal of Clinical Pathology. 113(1). 107–112. 11 indexed citations
2.
Segal, Glenn H., et al.. (1994). In Situ Hybridization Analysis of Lymphoproliferative Disorders. Diagnostic Molecular Pathology. 3(3). 170–177. 16 indexed citations
3.
Tubbs, Raymond R., Rafael Valenzuela, James T. McMahon, et al.. (1992). Pseudo-gamma heavy chain (IgG4 lambda) deposition disease.. PubMed. 5(2). 185–90. 26 indexed citations
4.
Rogers, Lisa R., P M Duchesneau, C Nuñez, et al.. (1992). Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis. Neurology. 42(6). 1239–1239. 58 indexed citations
5.
Segal, Glenn H., Andrew J. Fishleder, Mark H. Stoler, et al.. (1992). Precursor langerhans cell histiocytosis. Cancer. 70(2). 547–553. 25 indexed citations
6.
Segal, Glenn H., Mark Edinger, Michael D. Linden, et al.. (1991). Concomitant delineation of surface Ig, B‐cell differentiation antigens, and HLADR on lymphoid proliferations using three‐color immunocytometry. Cytometry. 12(4). 350–359. 23 indexed citations
7.
Segal, Glenn H., et al.. (1991). Reliable and Cost-Effective Paraffin Section Immunohistology of Lymphoproliferative Disorders. The American Journal of Surgical Pathology. 15(11). 1034–1041. 8 indexed citations
8.
Shin, Sung Sik, Khalil Sheibani, Andrew J. Fishleder, et al.. (1991). Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: A clinicopathologic study of 13 patients. Human Pathology. 22(5). 422–430. 61 indexed citations
9.
Fishleder, Andrew J.. (1990). Oncogenes and cancer: clinical applications. Cleveland Clinic Journal of Medicine. 57(8). 721–726. 4 indexed citations
10.
Linden, Michael D., et al.. (1989). Immunophenotypic spectrum of plasma cell leukemia. Cancer. 63(5). 859–862. 13 indexed citations
11.
Katzin, William E., Michael D. Linden, Andrew J. Fishleder, & Raymond R. Tubbs. (1989). Immunophenotypic and genotypic characterization of diffuse mixed non-Hodgkin's lymphomas.. PubMed. 135(4). 615–21. 16 indexed citations
12.
Calabrese, Leonard H., Melinda L. Estes, Belinda Yen‐Lieberman, et al.. (1989). Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis & Rheumatism. 32(5). 569–576. 102 indexed citations
13.
Fleming, Matthew G., et al.. (1989). Malignant angioendotheliomatosis: An angiotropic lymphoma. Journal of the American Academy of Dermatology. 21(4). 727–733. 31 indexed citations
14.
Katzin, William E., Andrew J. Fishleder, Michael D. Linden, & Raymond R. Tubbs. (1988). Immunoglobulin and T-cell receptor genes inthymomas: Genotypic evidence supporting the nonneoplastic nature of the lymphocytic component. Human Pathology. 19(3). 323–328. 10 indexed citations
15.
Linden, Michael D., Andrew J. Fishleder, William E. Katzin, & Raymond R. Tubbs. (1988). Absence of B-cell or T-cell clonal expansion in nodular, lymphocyte predominant Hodgkin's disease. Human Pathology. 19(5). 591–594. 26 indexed citations
16.
Lucas, Fred V., et al.. (1987). Acquired factor X deficiency in systemic amyloidosis. Cleveland Clinic Journal of Medicine. 54(5). 399–406. 4 indexed citations
17.
Fishleder, Andrew J. & George C. Hoffman. (1987). A Practical Approach to the Detection of Hemoglobinopathies: Part III. Nonsickling Disorders and Cord Blood Screening. Laboratory Medicine. 18(8). 513–518. 2 indexed citations
18.
Fishleder, Andrew J. & George C. Hoffman. (1987). A Practical Approach to the Detection of Hemoglobinopathies: Part II. The Sickle Cell Disorders. Laboratory Medicine. 18(7). 441–443. 2 indexed citations
19.
Ganapathi, Ram, et al.. (1985). Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometry. Investigational New Drugs. 3(3). 273–277. 6 indexed citations
20.
Tubbs, Raymond R., et al.. (1983). Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.. PubMed. 113(2). 207–21. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry A. Azar Breakdown of academic impact, for papers by F Deméocq Breakdown of academic impact, for papers by Leonardo Potenza Breakdown of academic impact, for papers by John M. Flexner Breakdown of academic impact, for papers by Maria Gilleece Breakdown of academic impact, for papers by J. E. Curtis Breakdown of academic impact, for papers by Tim H. Parmley Breakdown of academic impact, for papers by S Milan Breakdown of academic impact, for papers by WE Fibbe Breakdown of academic impact, for papers by Dennis P. O’Malley
Rankless by CCL
2026